Table 2.
Procedural Characteristics | |||
---|---|---|---|
H2O2-group (n = 429) | Control-group (n = 858) | P-value | |
Heart Rhythm Device | |||
Pacemaker [PM] | 197 (45.9%) | 409 (47.7%) | 0.59 |
Single Chamber PM | 23 (5.4%) | 60 (7.0%) | 0.28 |
Dual Chamber PM | 122 (28.4%) | 292 (34.0%) | 0.04* |
CRT-PM | 52 (12.1%) | 57 (6.6%) | <0.01* |
Implantable-Cardioverter-Defibrillator [ICD] | 230 (53.6%) | 397 (46.3%) | 0.01* |
Single Chamber ICD | 61 (14.2%) | 167 (19.5%) | 0.02* |
Dual Chamber ICD | 31 (7.2%) | 57 (6.6%) | 0.72 |
CRT-D | 138 (32.2%) | 173 (20.2%) | <0.01* |
Implantable-Loop-Recorder | 2 (0.5%) | 43 (5%) | <0.01* |
Cardiac Contractility Modulation | 0% | 9 (1.0%) | – |
Temporary Pacing | |||
Prior temporary pacing | 53 (12.7%) | 83 (9.7%) | 0.15 |
Duration [days] | 2.9 ± 1.8 | 3.3 ± 3.0 | 0.92 |
Implantation Procedure | |||
1st Procedure | 252 (58.7%) | 538 (62.7%) | 0.18 |
Follow-Up Intervention | 177 (41.3%) | 320 (37.3%) | 0.18 |
Generator exchange | 29 (6.8%) | 104 (12.1%) | <0.01* |
Device upgrade | 84 (19.6%) | 90 (10.5%) | <0.01* |
Device explantation | 17 (4.0%) | 35 (4.1%) | 1.0 |
Complications needing revision | 47 (11.0%) | 91 (10.6) | 0.84 |
Lead dysfunction | 35 (8.2%) | 78 (9.1%) | 0.60 |
Pocket Hematoma | 6 (1.4%) | 16 (1.9%) | 0.65 |
Device Placement | |||
Site of operation [left] | 367 (85.5%) | 740 (86.2%) | 0.73 |
Sub-cutaneous/sub-fascial | 392 (91.4%) | 757 (88.2%) | 0.13 |
Sub-muscular | 36 (8.4%) | 97 (11.3%) | 0.12 |
Venous Access | |||
Puncture (subclavian/axillary vein) | 378 (88.1%) | 667 (77.7%) | <0.01* |
Cephalic cut-down | 5 (1.2%) | 8 (0.9%) | 0.77 |
Wound Closure | |||
Intracutaneous suture | 21 (4.9%) | 189 (22.0%) | <0.01* |
Dermal Glue | 408 (95.1%) | 669 (77.9%) | <0.01* |
Bleeding Management | |||
Drainage | 50 (11.7%) | 117 (13.6%) | 0.33 |
D-stat Flowable Hemostat™ | 39 (9.1%) | 30 (3.5%) | <0.01* |